Abstract
Aim: There is a scarcity of data regarding gender and age related aspects of antiplatelet drugs utilization in the outpatient setting. Thus, the objective of the present study was to determine the age-and gender-related differences in the outpatient use of antiplatelet drugs in Alkharj.
Methodology: This is a retrospective study that include the assessment of electronic prescriptions in the outpatient setting that include an antiplatelet drug in 2018.
Results: Ticagrelor was prescribed mainly for patients more than 60 years old (84.62%). Clopidogrel was prescribed mainly for patients more than 50 years old (79.76%) and aspirin also was prescribed mainly for patients more than 50 years old (71.67%). Generally, most of the patients who received antiplatelet agents were male (52.76%).
Conclusion: The present study showed that there were differences in prescribing antiplatelet agents between different gender and different ages. So it is important to know the prescribing trends and to give the appropriate drugs based on several factors such as gender and age. It is expected that in the future, antiplatelet therapy may be based on age and on endogenous sex hormone level or genetic female/male differences.